NCT03655886View on ClinicalTrials.gov

Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Prostate Cancer Metastatic
Interventions
PROCEDURE

radical prostatectomy

can be performed either open, laparoscopic or robot-assisted, which is chosen by the discretion and expertise of the performing surgeon

RADIATION

Whole pelvis radiotherapy

radiation of prostate bed and pelvis

Trial Locations (6)

2650

Antwerp University Hospital, Edegem

3000

Leuven University Hospital, Leuven

8000

AZ Sint-Jan, Bruges

9000

AZ Jan Palfijn, Ghent

AZ Maria Middelares, Ghent

Unknown

University Hospital Ghent, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT03655886 - Cytoreductive Prostatectomy Versus Cytoreductive Prostate Irradiation As a Local Treatment Option for Metastatic Prostate Cancer: a Multicentric Feasibility Trial | Biotech Hunter | Biotech Hunter